Avalo Therapeutics, Inc. - Common Stock — 四半期キャッシュフロー (NASDAQ:AVTX) | MetaTrader

チャート全体を表示 Full chart

Financials

概要明細書統計

総資産 150.73 M138.52 M126.58 M125.1 M116.46 M99.89 M 負債合計 17.7 M15.91 M22.01 M33.55 M33.41 M31.57 M 純資産合計 133.03 M122.61 M104.57 M91.55 M83.05 M68.32 M 負債および純資産合計 150.73 M138.52 M126.58 M125.1 M116.46 M99.89 M 有利子負債合計 —————— 純負債 ——————

ニュース

This Small Biotech — Taking On AbbVie, Novartis And Sanofi — Just Catapulted Into A Breakout

CORT Rises on FDA Nod to Lifyorli in Platinum-Resistant Ovarian Cancer

BTIGによると今年のトップヘルスケア株

Top Healthcare Stocks for This Year According to BTIG

Avalo Therapeutics Stock Has More Than 200% Upside? Analyst Breaks Down Bull And Bear Case - Avalo Therapeutics (NASDAQ:AVTX)

アバロ・セラピューティクス株、ググンハイムのバイ評価開始で上昇

Avalo Therapeutics stock rises after Guggenheim initiates with Buy rating

グッゲンハイム、アバロ・セラピューティクスをIL-1β療法でBuy評価で開始

Guggenheim initiates Avalo Therapeutics stock with Buy rating on IL-1β therapy

アバロ・セラピューティクス株、治験データ発表前にH.C.ウェインライトがバイ評価を維持

Avalo Therapeutics stock maintains Buy rating at H.C. Wainwright ahead of trial data

This Valvoline Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Avalo Therapeutics (NASDAQ:AVTX), Lexeo Therapeutics (NASDAQ:LXEO)